[MOL] Re: [CancerDaily] Re: Leukemia Abstracts...... [02750]

LONING L, Zimmermann M, Reiter A, et al.
Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower
risk without cranial radiotherapy.
Blood 2000;95:2770-5.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779419&aid=B117149&dopt=r&s=leu

MAURO FR, Foa R, Cerretti R, et al.
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.
Blood 2000;95:2786-92.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779422&aid=B117149&dopt=r&s=leu

HALDER TM, Bluggel M, Heinzel S, Pawelec G, Meyer HE, Kalbacher H.
Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients
(plasmacytoma, chronic myeloid leukemia).
Blood 2000;95:2890-6.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779436&aid=B117149&dopt=r&s=leu

PALLIS M, Russell N.
P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated
with modulation of a sphingomyelin-ceramide apoptotic pathway.
Blood 2000;95:2897-904.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779437&aid=B117149&dopt=r&s=leu

LIPINSKI P, Drapier JC, Oliveira L, Retmanska H, Sochanowicz B, Kruszewski M.
Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell
lines differentially sensitive to H(2)O(2).
Blood 2000;95:2960-6.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779446&aid=B117149&dopt=r&s=leu

NGUYEN TT, Mohrbacher AF, Tsai YC, et al.
Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.
Blood 2000;95:2990-2.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10779450&aid=B117149&dopt=r&s=leu

SCHNITTGER S, Kinkelin U, Schoch C, et al.
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Leukemia 2000;14:796-804.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10803509&aid=B117149&dopt=r&s=leu

MARTIN-SOUDANT N, Drachman JG, Kaushansky K, Nepveu A.
CDP/Cut DNA binding activity is down-modulated in granulocytes, macrophages and erythrocytes but remains elevated in differentiating
megakaryocytes.
Leukemia 2000;14:863-73.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10803519&aid=B117149&dopt=r&s=leu

LUMINARI S, Intini D, Baldini L, et al.
BCL10 gene mutations rarely occur in lymphoid malignancies.
Leukemia 2000;14:905-8.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10803524&aid=B117149&dopt=r&s=leu

ELHASID R, Ben Arush MW, Pollack S, et al.
Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the
literature.
Leukemia 2000;14:931-4.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10803527&aid=B117149&dopt=r&s=leu

LANGABEER SE, Gale RE, Walker H, Linch DC.
Reported cryptic rearrangements of CBFbeta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA.
Leukemia 2000;14:944-5.

KERR R, Cunningham J, Bowen DT.
Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes.
Leukemia 2000;14:953.

CARELLA AM.
Autografting with non-clonal mobilized hematopoietic progenitor cells in CML.
Leukemia 2000;14:954-5.

PEDERSEN-BJERGAARD J, Andersen MK, Christiansen DH.
Therapy-related acute myeloid leukemia and myelodysplasia after high- dose chemotherapy and autologous stem cell transplantation.
Blood 2000;95:3273-9.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828005&aid=B117149&dopt=r&s=leu

SCHRAPPE M, Reiter A, Ludwig WD, et al.
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results
of trial ALL-BFM 90.
Blood 2000;95:3310-22.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828010&aid=B117149&dopt=r&s=leu

BARRETT AJ, Ringden O, Zhang MJ, et al.
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.
Blood 2000;95:3323-7.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828011&aid=B117149&dopt=r&s=leu

GUGLIELMI C, Arcese W, Hermans J, et al.
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT
retrospective analysis.
Blood 2000;95:3328-34.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828012&aid=B117149&dopt=r&s=leu

KITAMURA K, Aota Si, Sakamoto R, Yoshikawa SI, Okazaki K.
Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
Blood 2000;95:3371-9.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828018&aid=B117149&dopt=r&s=leu

VAN DER KOLK DM, Vellenga E, van Der Veen AY, et al.
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity.
Blood 2000;95:3514-9.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828037&aid=B117149&dopt=r&s=leu

SAHOTA SS, Davis Z, Hamblin TJ, Stevenson FK.
Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia.
Blood 2000;95:3534-40.

Abstract: http://www.amedeo.com/lit.cfm?uid=A10828040&aid=B117149&dopt=r&s=leu

RIVERA-LUNA R, Cardenas-Cardos R, Leal-Leal C, Meza-Coria C.
Leukemia in mexican versus mexican-american children.
J Clin Oncol 2000;18:2349-51.

REDDY V, Moreb J, Mehta P.
Donor lymphocyte infusions for CML: possible effects of age and mobilization.
Blood 2000;95:2994-5.

AGGERHOLM A, Hokland P.
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?.
Blood 2000;95:2997-9.

_________________________________________________________